Hastings Issues Early Warning Press Release Regarding Neo Performance Materials Inc.


Werte in diesem Artikel
Aktien

13.86 EUR -0.48 EUR -3.38 %

PERTH, Western Australia, Feb. 21, 2025 /CNW/ - Hastings Technology Metals Ltd. ("Hastings") announced today that its subsidiary, HTM Investments (One) Pty. Ltd. (the "Selling Shareholder"), has entered into a share purchase agreement (the "Agreement") with Wyloo Consolidated Investments Pty. Ltd. ("Wyloo") and has sold a significant portion of its equity interest in the outstanding common shares ("Common Shares") of Neo Performance Materials Inc. ("Neo") (TSX: NEO) to Wyloo  (the "Transaction"). 

Under the terms of the Agreement, the Selling Shareholder disposed of 8,350,311 Common Shares (the "Subject Shares") to Wyloo for consideration equal to CAD$8.63 per share, representing aggregate consideration of approximately CAD$72.1 million. Prior to the Transaction, Hastings (through the Selling Shareholder) held 8,974,127 Common Shares (including the Subject Shares), representing approximately 21.5% of the issued and outstanding Common Shares (based upon public disclosure made by Neo as to the number of outstanding Common Shares). Pursuant to the Transaction, Hastings has disposed of ownership of the Subject Shares, representing approximately 19.9% of the issued and outstanding Common Shares. Following completion of the Transaction, Hastings (through the Selling Shareholder) will hold 623,816 Common Shares, representing approximately 1.5% of the issued and outstanding Common Shares (based upon public disclosure made by Neo as to the number of outstanding Common Shares).

This press release is being issued pursuant to National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting Issuers ("NI 62-103") in connection with the Transaction. An early warning report with additional information in respect of the foregoing matters will be filed and made available on the System for Electronic Document Analysis and Review (SEDAR+) at www.sedarplus.ca under Neo's issuer profile.

Following the completion of the Transaction, Hastings intends to hold its remaining Common Shares for investment purposes. Hastings may from time to time, depending on market and other conditions, acquire additional Common Shares or dispose of Common Shares through market transactions, public offerings, private agreement or otherwise. No securities regulatory authority has either approved or disapproved of this news release

SOURCE Hastings Technology Metals Limited

Aktuelle Neogenomics Aktie News

Werbung

Neogenomics Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Neogenomics nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
DatumRatingAnalyst
01.05.19 Neogenomics Buy Needham & Company, LLC
29.03.19 Neogenomics Buy Needham & Company, LLC
03.01.19 Neogenomics Buy Needham & Company, LLC
24.10.18 Neogenomics Strong Buy First Analysis Securities
02.05.18 Neogenomics Equal-Weight First Analysis Securities

Information


Die Handels- und Depotfunktionen in diesem Broker Cockpit werden für Finanzinstrumente von der Finanzen.net Zero GmbH als vertraglich gebundener Vermittler der DonauCapital Wertpapier GmbH (§ 3 Abs. 2 WpIG) bereitgestellt; bei Kryptowerten werden die Handels- und Depotfunktionen in diesem Broker Cockpit ausschließlich von der DonauCapital Wertpapier GmbH bereitgestellt. Die Finanzen.net GmbH stellt ausschließlich den technischen Rahmen bereit und ist in die Wertpapier- und Kryptodienstleistung nicht einbezogen.